Novartis AG

NVS

Market cap$294.66 B

Rank#46

Filings981

Novartis AG has filed 981 public company documents between 2009 and 2026. The most frequent type is 6-k (561 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchNVS overview$294.66 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #46See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut NVS beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow NVS via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
6-K	6-K	7mo ago2025-11-25	2025-11-24	View filing
6-K	6-K	7mo ago2025-11-20	2025-11-20	View filing
6-K	6-K	8mo ago2025-11-05	2025-11-05	View filing
424B5	Prospectus supplement	8mo ago2025-11-04	-	View filing
FWP	Free writing prospectus	8mo ago2025-11-04	-	View filing
424B5	Prospectus supplement	8mo ago2025-11-03	-	View filing
6-K	6-K	8mo ago2025-10-28	2025-09-30	View filing
DFAN14A	DFAN14A	8mo ago2025-10-28	-	View filing
3	New insider ownership	8mo ago2025-10-28	2025-10-28	View filing
SC TO-T/A	SC TO-T/A	8mo ago2025-10-28	-	View filing
DFAN14A	DFAN14A	8mo ago2025-10-28	-	View filing
6-K	6-K	8mo ago2025-10-27	2025-10-27	View filing
DFAN14A	DFAN14A	8mo ago2025-10-27	-	View filing
DFAN14A	DFAN14A	8mo ago2025-10-27	-	View filing
DFAN14A	DFAN14A	8mo ago2025-10-27	-	View filing
SC TO-T/A	SC TO-T/A	8mo ago2025-10-22	-	View filing
SC TO-T/A	SC TO-T/A	8mo ago2025-10-20	-	View filing
6-K	6-K	9mo ago2025-09-30	2025-09-30	View filing
SC TO-T	SC TO-T	9mo ago2025-09-29	-	View filing
SC TO-C	SC TO-C	10mo ago2025-09-09	-	View filing
6-K	6-K	11mo ago2025-08-11	2025-08-11	View filing
6-K	6-K	11mo ago2025-07-17	2025-06-30	View filing
6-K	6-K	11mo ago2025-07-17	2025-07-17	View filing
SCHEDULE 13G	SCHEDULE 13G	11mo ago2025-07-17	-	View filing
SC TO-T/A	SC TO-T/A	1y ago2025-06-25	-	View filing
SC TO-T/A	SC TO-T/A	1y ago2025-06-23	-	View filing
SC TO-T/A	SC TO-T/A	1y ago2025-06-17	-	View filing
6-K	6-K	1y ago2025-06-02	2025-04-03	View filing
SC TO-T	SC TO-T	1y ago2025-05-27	-	View filing
144	Insider sale notice	1y ago2025-05-23	-	View filing
SC TO-C	SC TO-C	1y ago2025-05-01	-	View filing
144	Insider sale notice	1y ago2025-04-30	-	View filing
SC TO-C	SC TO-C	1y ago2025-04-30	-	View filing
6-K	6-K	1y ago2025-04-29	2025-03-31	View filing
UPLOAD	SEC correspondence	1y ago2025-04-08	-	View filing
6-K	6-K	1y ago2025-04-03	2025-04-03	View filing
CORRESP	Company correspondence	1y ago2025-03-31	-	View filing
6-K	6-K	1y ago2025-03-28	2025-03-28	View filing
UPLOAD	SEC correspondence	1y ago2025-03-18	-	View filing
6-K	6-K	1y ago2025-01-31	2024-12-31	View filing
6-K	6-K	1y ago2025-01-31	2024-12-31	View filing
IRANNOTICE	IRANNOTICE	1y ago2025-01-31	-	View filing
20-F	20-F	1y ago2025-01-31	2024-12-31	View filing

Novartis AG

Similar companies to research next

Year